Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- IOPAIndependent statistical analysis of A Study for Patients With Diabetes Mellitus (IOPA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00420095).
- Iota-Carrageenan Nasal Spray in Common Cold: Complete Statistical AnalysisIndependent statistical analysis of Iota-Carrageenan Nasal Spray in Common Cold: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01944631).
- IPACIndependent statistical analysis of Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy: primary endpoint…
- IPATunity130Independent statistical analysis of A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer:…
- IPCDIndependent statistical analysis of Impact of Pharmaceutical Care in Diabetics Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01580904).
- IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02803580).
- IPF-201Independent statistical analysis of Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD: Complete Statistical AnalysisIndependent statistical analysis of IPL and Meibomian Gland Expression to Treat Ocular Rosacea Ocular GVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IPOD-AVIndependent statistical analysis of Assessing the Incidence of Postoperative Delirium Following Aortic Valve Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03950440).
- iPOP-UPIndependent statistical analysis of Dissemination and Implementation of Improving Pediatric Obesity Practice Using Prompts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05627011).
- IQSIndependent statistical analysis of Improving Quitline Support Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03538938).
- iQuit Mindfully: Text Messaging for Smoking Cessation: Complete Statistical AnalysisIndependent statistical analysis of iQuit Mindfully: Text Messaging for Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03029819).
- IRC002Independent statistical analysis of Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery: primary endpoint results,…
- IRISComplete statistical analysis of the IRIS trial of pioglitazone versus placebo after stroke or myocardial infarction, including trial design, time-to-event endpoints, Cox modeling, mixed-effects analysis, multiplicity, interim analysis, results, and statistical interpretation.
- Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA): Complete Statistical AnalysisIndependent statistical analysis of Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments: Complete Statistical AnalysisIndependent statistical analysis of Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments: primary endpoint results, effect estimate with confidence interval, sample-size…
- Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections: Complete Statistical AnalysisIndependent statistical analysis of Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth: Complete Statistical AnalysisIndependent statistical analysis of Irritation and Sensitization of Chlorhexidine Gluconate (CHG) Cloth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02224625).
- Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT: Complete Statistical AnalysisIndependent statistical analysis of Irritation Potential of Omeza Collagen Matrix Using Modified HRIPT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04510675).
- Is Non-Cardiac Chest Pain Caused by Sustained Longitudinal Smooth Muscle Contraction?: Complete Statistical AnalysisIndependent statistical analysis of Is Non-Cardiac Chest Pain Caused by Sustained Longitudinal Smooth Muscle Contraction?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Is Topical CBD Effective in Treating Thumb Joint Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Is Topical CBD Effective in Treating Thumb Joint Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04611347).
- ISABELA1Independent statistical analysis of A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care: primary endpoint results,…
- ISABELA2Independent statistical analysis of A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care: primary endpoint results,…
- Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011): Complete Statistical AnalysisIndependent statistical analysis of Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Islet Transplantation for Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Islet Transplantation for Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00014911).
- iSmartHypIndependent statistical analysis of The Smart Hypertension Control Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03288142).
- IsoCOMFORTIndependent statistical analysis of Effect & Safety of Inhaled Isoflurane vs IV Midazolam for Sedation in Mechanically Ventilated Children 3-17 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Isoflurane Preconditioning for Liver Resections: Complete Statistical AnalysisIndependent statistical analysis of Isoflurane Preconditioning for Liver Resections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01031550).
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ISS-DMIIIndependent statistical analysis of Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ISTEPIndependent statistical analysis of Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03860818).
- Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8): Complete Statistical AnalysisIndependent statistical analysis of Isthmus Ablation With Gold Electrode for Treatment of Atrial Flutter (AURUM 8): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ISV-305Independent statistical analysis of 2nd Study to Assess ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Itacitinib + Everolimus in Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Itacitinib + Everolimus in Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03697408).
- Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation: primary endpoint…
- iTAP-VIndependent statistical analysis of The Insomnia Treatment and Problems Study for Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03804788).
- ITICIndependent statistical analysis of A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size…
- iTOMIndependent statistical analysis of Medical Therapy Versus Radiofrequency Endometrial Ablation in the Initial Treatment of Menorrhagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ITPIndependent statistical analysis of Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00699140).
- ITT4Independent statistical analysis of ITT4 Intratesticular Hormonal Milieu in Man (ITT4): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01215292).
- IUD@CSDIndependent statistical analysis of Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- IV Acetaminophen for Postoperative Pain After Pelvic Organ Prolapse Repair: Complete Statistical AnalysisIndependent statistical analysis of IV Acetaminophen for Postoperative Pain After Pelvic Organ Prolapse Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02155738).
- IV Acetaminophen for Postoperative Pain Analgesia After Laparoscopic Hysterectomy: Complete Statistical AnalysisIndependent statistical analysis of IV Acetaminophen for Postoperative Pain Analgesia After Laparoscopic Hysterectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02400580).
- IV Acetaminophen vs IV Morphine for Pain Control in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of IV Acetaminophen vs IV Morphine for Pain Control in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis: Complete Statistical AnalysisIndependent statistical analysis of IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- iVASTIndependent statistical analysis of The Intra-arterial Vasospasm Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01996436).
- IVF Hyper-responders: Oocyte Vitrification Compared With Embryo Freezing: Complete Statistical AnalysisIndependent statistical analysis of IVF Hyper-responders: Oocyte Vitrification Compared With Embryo Freezing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02026193).